Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
During the past 20 years, several types of human papillomaviruses (HPVs) have been identified that cause specific types of cancers. The etiology of cancer of the cervix has been linked to several types of HPV, with a high preponderance of HPV16. The role of these virus infections has been established 1) by the regular presence of HPV DNA in the respective tumor biopsy specimens, 2) by the demonstration of viral oncogene expression (E6 and E7) in tumor material, 3) by the identification of transforming properties of these genes, 4) by the requirement for E6 and E7 expression for maintaining the malignant phenotype of cervical carcinoma cell lines, 5) by the interaction of viral oncoproteins with growth-regulating host-cell proteins, and 6) by epidemiologic studies pointing to these HPV infections as the major risk factor for cervical cancer development. In addition to cancer of the cervix, a major proportion of anal, perianal, vulvar, and penile cancers appears to be linked to the same HPV infections. In addition, close to 20% of oropharyngeal cancers contain DNA from the same types of HPV. Recent evidence also points to a possible role of other HPV infections in squamous cell carcinomas of the skin. This review covers recent developments in understanding molecular mechanisms of HPV carcinogenesis, mainly discussing functions of viral oncoproteins and the regulation of viral oncogenes by host-cell factors. Modifications in host-cell genes, most likely engaged in the control of HPV gene expression in proliferating cells, emerge as important events in HPV-mediated carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · cited 2×
“Münger and Phelps, 1993 (121) Arroyo et al., 1993(51), Zerfass et al., 1995 Dyson et al., 1989, 1992 (39,40) Puthenveettil et al., 1996 (59) Jones et al., 1997(57), Funk et al., 1997(56) Kessis et al., 1996(22), Reznikoff et al., 1996(31) Oda et al., 1999(24) Journal of the National Cancer…”
BackgroundAssociation of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Papillomavirus infections — a major cause of human cancers
Hausen, H. Z. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00020-0 · Cited by 1,513
Self-citationStructure and transcription of human papillomavirus sequences in cervical carcinoma cells
Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483
Self-citationKiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Human papillomaviruses in the pathogenesis of anogenital cancer
zur Hausen, H. (1991) · Virology · doi:10.1016/0042-6822(91)90816-t · Cited by 847
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
Hawley‐Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., & Schiller, J. T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08570.x · Cited by 733
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 660
Sano, T., Oyama, T., Kashiwabara, K., Fukuda, T., & Nakajima, T. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65689-1 · Cited by 579
Ronco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 544
Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., & Ishibashi, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11612 · Cited by 428
Funk, J. O., Waga, S., Harry, J. B., Espling, E., Stillman, B., & Galloway, D. A. (1997) · Genes & Development · doi:10.1101/gad.11.16.2090 · Cited by 419
Human papillomavirus type 16 and 18 gene expression in cervical neoplasias
Stoler, M. H., Rhodes, C. R., Whitbeck, A., Wolinsky, S. M., Chow, L. T., & Broker, T. R. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90232-r · Cited by 409
Jones, D. L., Alani, R. M., & Münger, K. (1997) · Genes & Development · doi:10.1101/gad.11.16.2101 · Cited by 378
White, A. E., Livanos, E. M., & Tlsty, T. D. (1994) · Genes & Development · doi:10.1101/gad.8.6.666 · Cited by 368
Pereira-Smith, O. M., & Smith, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6042 · Cited by 351
c-fos is required for malignant progression of skin tumors
Saez, E., Rutberg, S. E., Mueller, E., Oppenheim, H., Smoluk, J., Yuspa, S. H., & Spiegelman, B. M. (1995) · Cell · doi:10.1016/0092-8674(95)90469-7 · Cited by 346
Bagchi, S., Raychaudhuri, P., & Nevins, J. R. (1990) · Cell · doi:10.1016/0092-8674(90)90112-r · Cited by 341
Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein.
Zerfass, K., Zwerschke, W., Mannhardt, B., Tindle, R. W., Botz, J. W., & Jansen‐Dürr, P. (1996) · PubMed · Cited by 333
Dyson, N., Guida, P., Münger, K., & Harlow, E. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.6893-6902.1992 · Cited by 314
Band, V, Zajchowski, D., Kulesa, V, & Sager, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.463 · Cited by 299
Tartour, É., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E. J., Sastre‐Garau, X., Couturier, J., Mosseri, V., Vives, V., et al. (1999) · PubMed · Cited by 290
Interaction of Papillomavirus E6 Oncoproteins with a Putative Calcium-Binding Protein
Chen, J. J., Reid, C. E., Band, V., & Androphy, E. J. (1995) · Science · doi:10.1126/science.7624774 · Cited by 275
Cyclin A and the retinoblastoma gene product complex with a common transcription factor
Bandara, L. R., Adamczewski, J. P., Hunt, T., & La Thangue, N. B. (1991) · Nature · doi:10.1038/352249a0 · Cited by 274
Human Pathogenic Papillomavirus Types: An Update
de Villiers, E. M. (1994) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78487-3_1 · Cited by 270
The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton
Tong, X., & Howley, P. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4412 · Cited by 268
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
Brehm, A., Nielsen, S. J., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2449 · Cited by 267
INTRACELLULAR SURVEILLANCE OF PERSISTING VIRAL INFECTIONS
Hausen, H. Z. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90360-0 · Cited by 260
Self-citationConrad, M., Bubb, V. J., & Schlegel, R. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6170-6178.1993 · Cited by 248
Inhibition of Bak-induced apoptosis by HPV-18 E6
Thomas, M., & Banks, L. (1998) · Oncogene · doi:10.1038/sj.onc.1202223 · Cited by 241
Papillomaviruses in Human Cancers
Hausen, H. Z. (2003) · Infectious Causes of Cancer · doi:10.1385/1-59259-024-1:245 · Cited by 238
Self-citationThe Human Papillomavirus E7 Oncoprotein Abrogates Signaling Mediated by Interferon-α
Barnard, P., & McMillan, N. A. J. (1999) · Virology · doi:10.1006/viro.1999.9771 · Cited by 227
p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.
Havre, P. A., Yuan, J., Hedrick, L., Cho, K. R., & Glazer, P. M. (1995) · PubMed · Cited by 223
Modulation of type M 2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein
Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., Eigenbrodt, E., & Jansen-Dürr, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1291 · Cited by 223
Davies, R., Hicks, R., Crook, T., Morris, J., & Vousden, K. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2521-2528.1993 · Cited by 212
Gao, Q., Srinivasan, S., Boyer, S. N., Wazer, D. E., & Band, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.733 · Cited by 188
(1996) · PubMed · Cited by 180
Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination
Oda, H., Kumar, S., & Howley, P. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9557 · Cited by 177
Jewers, R. J., Hildebrandt, P., Ludlow, J. W., Kell, B., & McCance, D. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1329-1335.1992 · Cited by 174
Demers, G. W., Foster, S. A., Halbert, C. L., & Galloway, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4382 · Cited by 172
Bergers, G., Graninger, P., Braselmann, S., Wrighton, C., & Busslinger, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3748 · Cited by 167
Thomas, M., & Banks, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-6-1513 · Cited by 166
Antinore, M. J., Birrer, M. J., Patel, D., Nader, L., & McCance, D. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00546.x · Cited by 165
The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in golgi and plasma membranes
Burkhardt, A. L., Willingham, M. C., Gay, C. G., Jeang, K.-T., & Schlegel, R. (1989) · Virology · doi:10.1016/0042-6822(89)90391-7 · Cited by 155
Human Papillomavirus E7 Oncoproteins Bind a Single Form of Cyclin E in a Complex with cdk2 and p107
McIntyre, M., Ruesch, M. N., & Laimins, L. A. (1996) · Virology · doi:10.1006/viro.1996.0008 · Cited by 151
Berezutskaya, E., & Bagchi, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30135 · Cited by 148
Zerfass, K., Schulze, A., Spitkovsky, D., Friedman, V, Henglein, B., & Jansen-Dürr, P. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6389-6399.1995 · Cited by 147
von Knebel Doeberitz, M., Rittmüller, C., Aengeneyndt, F., Jansen-Dürr, P., & Spitkovsky, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2811-2821.1994 · Cited by 146
Pol, S. V., Brown, M. C., & Turner, C. E. (1998) · Oncogene · doi:10.1038/sj.onc.1201504 · Cited by 136
Hwang, E.-S., Nottoli, T., & Dimaio, D. (1995) · Virology · doi:10.1006/viro.1995.1395 · Cited by 136
p53 polymorphism and risk of cervical cancer
Helland, Å., Langerød, A., Johnsen, H., Olsen, A. O., Skovlund, E., & Børresen‐Dale, A. (1998) · Nature · doi:10.1038/25034 · Cited by 134
Functions of Human Papillomavirus Proteins
Scheffner, M., Romanczuk, H., Münger, K., Huibregtse, J. M., Mietz, J. A., & Howley, P. M. (1994) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78487-3_5 · Cited by 132
Reznikoff, C. A., Belair, C., Savelieva, E., Zhai, Y., Pfeifer, K., Yeager, T., Thompson, K. J., DeVries, S., Bindley, C., & Newton, M. A. (1994) · Genes & Development · doi:10.1101/gad.8.18.2227 · Cited by 129
Li, J. J., Rhim, J. S., Schlegel, R., Vousden, K. H., & Colburn, N. H. (1998) · Oncogene · doi:10.1038/sj.onc.1201798 · Cited by 126
Rb binds c‐Jun and activates transcription
Nead, M. A., Baglia, L. A., Antinore, M. J., Ludlow, J. W., & McCance, D. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2342 · Cited by 125
Woodworth, C. D., Notario, V., & DiPaolo, J. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4767-4775.1990 · Cited by 123
Steenbergen, R. D. M., Walboomers, J. M. M., Meijer, C. J. L. M., van der Raaij-Helmer, E. M. H., Parker, J., Chow, L. T., Broker, T. R., & Snijders, P. J. F. (1996) · PubMed · Cited by 122
Bartsch, D., Boye, B., Baust, C., Hausen, H. Z., & Schwarz, E. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05287.x · Cited by 121
Self-citationExpression of SV40 T antigen in finite life-span hybrids of normal and SV40-transformed fibroblasts
Pereira‐Smith, O. M., & Smith, J. R. (1981) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01542986 · Cited by 119
Crook, T., Storey, A., Almond, N., Osborn, K., & Crawford, L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8820 · Cited by 118
Stöppler, H., Hartmann, D.-P., Sherman, L., & Schlegel, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13332 · Cited by 115
Dalgleish, A. G. (1991) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072457 · Cited by 115
Dürst, M., Bosch, F. X., Glitz, D., Schneider, A., & Hausen, H. Z. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.796-804.1991 · Cited by 112
Self-citationImmortalization and Transformation of Human Cells by Human Papillomavirus
McDougall, J. K. (1994) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78487-3_6 · Cited by 111
Martin, L. G., Demers, G. W., & Galloway, D. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.975-985.1998 · Cited by 109
The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis
Stöppler, H., Stoppler, M. C., Johnson, E., Simbulan-Rosenthal, C. M., Smulson, M. E., Iyer, S., Rosenthal, D. S., & Schlegel, R. (1998) · Oncogene · doi:10.1038/sj.onc.1202053 · Cited by 106
Expression of HPV16 E6 or E7 increases integration of foreign DNA.
Kessis, T. D., Connolly, D. C., Hedrick, L., & Cho, K. R. (1996) · PubMed · Cited by 105
Schilling, B., De-Medina, T., Syken, J., Vidal, M., & Münger, K. (1998) · Virology · doi:10.1006/viro.1998.9220 · Cited by 103
Genital papillomavirus infections.
Hausen, H. Z. (1985) · PubMed · Cited by 101
Self-citationThe E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II.
Firzlaff, J. M., Galloway, D. A., Eisenman, R. N., & Lüscher, B. (1989) · PubMed · Cited by 97
Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells.
Chen, T., Pecoraro, G., & Defendi, V. (1993) · PubMed · Cited by 97
Soto, U., Das, B. C., Lengert, M., Finzer, P., Hausen, H. Z., & Rösl, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202765 · Cited by 97
Self-citationThe human papillomavirus E7 protein as a transforming and transactivating factor
Münger, K., & Phelps, W. C. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90025-8 · Cited by 94
Kyo, S., Klumpp, D. J., Inoue, M., Kanaya, T., & Laimins, L. A. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-2-401 · Cited by 89
Bosch, F. X., Schwarz, E., Boukamp, P., Fusenig, N. E., Bartsch, D., & Hausen, H. Z. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4743-4754.1990 · Cited by 86
Self-citationMassimi, P., Pim, D., & Banks, L. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-10-2607 · Cited by 85
Massimi, P., Pim, D., Storey, A., & Banks, L. (1996) · PubMed · Cited by 85
Crusius, K., Auvinen, E., & Alonso, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201312 · Cited by 81
Xiong, Y., Kuppuswamy, D., Li, Y., Livanos, E. M., Hixon, M., White, A., Beach, D., & Tlsty, T. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.999-1008.1996 · Cited by 80
Rösl, F., Lengert, M., Albrecht, J., Kleine, K., Zawatzky, R., Schraven, B. L., & Hausen, H. Z. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2142-2150.1994 · Cited by 76
Self-citationStorey, A., Oates, D. J., Banks, L., Crawford, L. V., & Crook, T. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4109 · Cited by 74
Effect of human papillomavirus type 16 oncogenes on MAP kinase activity
Gu, Z., & Matlashewski, G. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.8051-8056.1995 · Cited by 62
Iglesias, M., Yen, K., Gaiotti, D., Hildesheim, A., Stoler, M. H., & Woodworth, C. D. (1998) · Oncogene · doi:10.1038/sj.onc.1202054 · Cited by 54
Venturini, F. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.7.1585 · Cited by 52
Shnitman Magal, S., Jackman, A., Pei, X. F., Schlegel, R., & Sherman, L. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980105)75:1<96::aid-ijc15>3.0.co;2-b · Cited by 51
Hu, G., Liu, W., Hanania, E. G., Fu, S., Wang, T., & Deisseroth, A. B. (1995) · PubMed · Cited by 45
Smits, P. H. M., Smits, H. L., Minnaar, R. P., Hemmings, B. A., Mayer-Jaekel, R. E., Schuurman, R., van der Noordaa, J., & ter Schegget, J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05562.x · Cited by 40
Cotransfection of HPV-18 and v-fos DNA induces tumorigenicity of primary human keratinocytes
Pei, X. F., Meck, J. M., Greenhalgh, D., & Schlegel, R. (1993) · Virology · doi:10.1006/viro.1993.1546 · Cited by 39
Seagon, S., & Dürst, M. (1994) · PubMed · Cited by 27
Bornstein, J., Lahat, N., Kinarty, A., Revel, M., Abramovici, H., & Shapiro, S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970301)79:5<924::aid-cncr9>3.0.co;2-b · Cited by 18
Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes.
Medina-Martínez, O., Vallejo‐Ruiz, V., Guido, M. C., & García-Carrancá, A. M. (1997) · PubMed · Cited by 17
(1996) · PubMed
Cited by
Papillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104
“The dichotomous division of SIL reflects the substantial virological, molecular, and clinical evidence that LSIL is generally a transient infection with HPV, while HSIL is more often associated with viral persistence and higher risk for progression.(10-13) In addition, data from the ASCUS LSIL Triage Study demonstrate…”
MethodVaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Lowik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Essahsah, F., Fathers, L. M., Offringa, R., Drijfhout, J. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810097 · Cited by 1,102
Klaes, R., Friedrich, T., Spitkovsky, D., Ridder, R., Rudy, W., Petry, U., Dallenbach-Hellweg, G., Schmidt, D., & von Knebel Doeberitz, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1174 · Cited by 1,035
Metadata
- Authors
- Hausen, H. Z.
- Venue
- Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-05-03
- Volume
- 92
- Issue
- 9
- Pages
- 690-698
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2143019738
- Cited by
- 1,298
- References
- 95
- FWCI
- 52.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.